glp 1 formulary Impact of the CVS GLP-1 change: Trends in switching free green tea extract with 50% EGCG The GLP-1 Revolution Continues

Systematic Treatment for Unresectable Stage III, Stage IV, and Recurrent Disease Treatment options for patients with metastatic melanoma have rapidly expanded over the last decade

Beginning in 2027, Colorado insurers must offer optional coverage for FDA-approved anti-obesity medications, including at least one GLP-1 medication

There's a lot to unpack, so we've structured our thoughts into three distinct sectionsfeel free to peruse the whole post or jump forward to specific areas of interest using the links below: We'll start by sharing our about where the innovation race is headingand what it means for the industry key insights and predictions From there, we'll overview (including key differentiators between major competitors Eli Lilly and Novo Nordisk) what the race has looked to date Finally, we'll go deep on the that will define the innovation race moving forward: five vectors of innovation GLP-1 innovation: Key insights and predictions GLP-1s are more than a blockbuster drug class, they signal a profound reordering of how chronic disease is managed, financed, and even understood

Solid protein, like meat, can be genuinely hard to get through in this window

In the U.S., list prices for GLP-1-based medications are up to $1,000 or more a month before insurance

J Biol Chem 285:4152532